Study SOLACE SEPSIS
NCT06634069 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2026-04-14
Summary
A Pilot, Randomized, Double-Blinded, Controlled Study of Hemodynamic and Acid Base Effects of 0.5M Sodium Lactate and 3% Saline Solutions in Septic Shock Patients
Conditions
- Septic Shock
- Intracranial Hypertension
Interventions
- DRUG
-
Sodium Lactate
0.5M HSL (containing 504mM of sodium and lactate)
- DRUG
-
3% NaCl
active compartor 3% NaCl
Sponsors & Collaborators
-
University Hospital Pilsen
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-11-24
- Primary Completion
- 2027-10-31
- Completion
- 2027-10-31
- FDA Drug
- Yes
Countries
- Czechia
Study Locations
More Related Trials
-
Vasopressin Plasma Concentrations in Patients Receiving Exogenous Vasopressin Infusion for Septic Shock
NCT03014063 ·Status: COMPLETED
-
Selenium, as Sodium Selenite, in the Treatment of Septic Shock
NCT00207844 ·Status: COMPLETED ·Phase: PHASE2
-
Ventriculo-arterial Coupling and Myocardial Work in Sepsis and Septic Shock
NCT06853574 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock
NCT03335124 ·Status: TERMINATED ·Phase: PHASE4
-
Piperacillin/Tazobactam in Critically Ill Patients With Severe Sepsis and Septic Shock
NCT02730624 ·Status: COMPLETED ·Phase: PHASE4
-
Preemptive Resuscitation for Eradication of Septic Shock
NCT01449721 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients With Septic Shock
NCT00604214 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Lactate Clearance Oriented Haemodynamic Therapy on the Outcome of Patients With Septic Shock
NCT02566460 ·Status: COMPLETED ·Phase: NA
-
Systematic Adjunction of Vasopressine in Septic Shock
NCT07052084 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Therapeutic Effect of Sodium Selenite on Oxidative Stress in Patients With Severe Sepsis
NCT02026856 ·Status: COMPLETED
-
Effect of Vasopressin on Kidney and Cardiac Function in Septic Shock
NCT06125184 ·Status: RECRUITING ·Phase: NA
-
Selepressin Evaluation Programme for Sepsis-Induced Shock - Adaptive Clinical Trial
NCT02508649 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Dopamine Versus Norepinephrine for the Treatment of Vasopressor Dependent Septic Shock
NCT00604019 ·Status: COMPLETED ·Phase: PHASE3
-
Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis
NCT03434028 ·Status: COMPLETED ·Phase: PHASE3
-
Plasmaexchange in Early Septic Shock
NCT03065751 ·Status: UNKNOWN ·Phase: NA
-
Fluid Intolerance Signals as Safety Limits to Prevent Fluid-induced Harm During Septic Shock Resuscitation
NCT06568744 ·Status: RECRUITING ·Phase: NA
-
A Clinical Trial of Procalcitonin-guided Antimicrobial Therapy in Sepsis
NCT03333304 ·Status: COMPLETED ·Phase: NA
-
Modulation of Vasoreactivity in Septic Shock: Impact of Recombinant Protein C
NCT02885168 ·Status: COMPLETED ·Phase: PHASE4
-
Gelatin in ICU and Sepsis
NCT02715466 ·Status: TERMINATED ·Phase: PHASE4
-
Protocol-driven Hemodynamic Support for Patients With Septic Shock
NCT00335907 ·Status: UNKNOWN ·Phase: NA
-
Hydrocortisone for Prevention of Septic Shock
NCT00670254 ·Status: COMPLETED ·Phase: PHASE3
-
Hyperoxia and Hypertonic Saline in Septic Shock
NCT01722422 ·Status: TERMINATED ·Phase: NA
-
Adrenomedullin and Outcome in Severe Sepsis and Septic Shock
NCT02393781 ·Status: COMPLETED
-
Lactate Kinetics in Septic Shock
NCT05349370 ·Status: RECRUITING ·Phase: NA
-
Comparison of Vasopressin and Other Pressors in Septic Shock
NCT00269685 ·Status: COMPLETED ·Phase: PHASE2/PHASE3